Clinical Trials Browser

Astrocytoma, Ganglioneuroma, Glioblastoma, Glioma, Histiocytosis, Langerhans-Cell, Neuroblastoma, Neurofibromatosis 1, Oligodendroglioma, Ganglioglioma, Neurocytoma, Neurofibroma, Plexiform

NCT05161195 2026-04-02

Roll-over Study to Allow Continued Access to Ribociclib

Phase 4 Active not recruiting

134 enrolled

Breast

Breast Neoplasms

NCT05252585 2026-04-02

A Phase IV Study of Safety and Efficacy of Everolimus in Taiwanese Patients With Tuberous Sclerosis Complex Who Have Renal Angiomyolipoma (TSC-AML)

Phase 4 Active not recruiting

4 enrolled

Tuberous Sclerosis, Angiomyolipoma

NCT05754528 2026-04-02

REaCT-TEMPO

Phase 4 Active not recruiting

240 enrolled

Breast

Breast Neoplasms

NCT01742299 2026-04-01

Study to Allow Access to Imatinib for Patients Who Are on Imatinib Treatment in a Novartis-sponsored Study and Are Benefiting From the Treatment as Judged by the Investigator

Phase 4 Active not recruiting

155 enrolled

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT03340506 2026-04-01

Dabrafenib and/or Trametinib Rollover Study

Phase 4 Recruiting

100 enrolled

CNSDermatologicThoracic

Carcinoma, Non-Small-Cell Lung, Glioma, Lung Neoplasms, Melanoma

NCT07490509 2026-04-01

DOSABEMA

Phase 4 Not yet recruiting

235 enrolled

Breast

Breast Neoplasms

NCT07504796 2026-04-01

ctDNA-guided Addition of Ipilimumab to Patients Receiving Nivolumab and Relatlimab

Phase 4 Not yet recruiting

90 enrolled

Dermatologic

Melanoma

NCT02555748 2026-03-31

SUP-R

Phase 4 Completed

47 enrolled

Genitourinary

Carcinoma, Renal Cell

NCT02366819 2026-03-30

Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer

Phase 4 Suspended

36 enrolled

Gastrointestinal

Adenocarcinoma Of Esophagus, Stomach Neoplasms

NCT05160922 2026-03-30

Crizotinib Continuation Clinical Study

Phase 4 Active not recruiting

27 enrolled

LymphoidPlasma cellThoracic

Carcinoma, Non-Small-Cell Lung, Granuloma, Plasma Cell, Lymphoma, Large-Cell, Anaplastic

NCT06031233 2026-03-30

MINUTE

Phase 4 Recruiting

776 enrolled

Tumor-Agnostic

Neoplasms

NCT06183437 2026-03-30

STOP-MED CTRCD

Phase 4 Recruiting

335 enrolled

Heart Failure, Neoplasms, Cardiotoxicity

NCT07287826 2026-03-30

SMILE

Phase 4 Recruiting

45 enrolled

Stomatitis

NCT07502027 2026-03-30

A Clinical Study of Iparomlimab and Tuvonralimab Combined With SOX Following Heterogeneous Radiotherapy as First-line Treatment for Unresectable Locally Advanced or Metastatic HER2-negative Gastric or Gastroesophageal Junction Adenocarcinoma

Phase 4 Not yet recruiting

55 enrolled

Gastrointestinal

Disease, Stomach Neoplasms

NCT03144206 2026-03-27

Hyperbaric Oxygen Therapy for Soft Tissue Sarcoma Pilot Study

Phase 4 Active not recruiting

20 enrolled

Sarcoma

NCT07246564 2026-03-27

Phase 4 Study Evaluating Efficacy and Safety of Rozanolixizumab in Adult Chinese Participants With Generalized Myasthenia Gravis

Phase 4 Recruiting

40 enrolled

Myasthenia Gravis

NCT04266665 2026-03-25

Effect of Dexmedetomidine on Brain Homeostasis and Neurocognitive Outcome

Phase 4 Completed

56 enrolled

CNS

Neuroinflammatory Diseases, Hypoxia, Brain Neoplasms

NCT06423235 2026-03-24

ESPTTN

Phase 4 Recruiting

234 enrolled

Head & Neck

Thyroid Nodule

Clinical Trials

MagnetisMM15

PRECISE AM

RADIANT: A Study of Radium-223 Dichloride (Xofigo) vs Enzalutamide or Abiraterone (ARPIs, Androgen Receptor Pathway Inhibitors) in Patients With Prostate Cancer That Has Spread to the Bones (mCRPC, Metastatic Castration-Resistant Prostate Cancer)

Acalabrutinib Monotherapy vs Investigator's Choice of Treatment in Patients With CL Leukaemia and Heart Failure

PHACS

OXYTAM

MIRHO

IPIAP-STM

People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents

A Study to Assess Safety of Teclistamab in Indian Participants With Relapsed and Refractory Multiple Myeloma

A Study of Apalutamide in Chinese Participants With Non Metastatic Castration Resistant Prostate Cancer (NM-CRPC)

ParOP

A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel

PRISMA

RESToRE

Usage of 5-fluorouracil and Carnoy's Solution in Surgical Treatment of Odontogenic Keratocysts

Effect of Misoprostol on Fluid Deficit Volume in Hysteroscopic Myomectomy

Lorlatinib in Patients With ALK-Positive NSCLC With Brain or Leptomeningeal Metastases

TDXdose

A Study of Antibiotic Delivery to Prevent Infection After Breast Tissue Expander Placement

OCTAGON

Comparing Continuation or De-escalation of Bone Modifying Agents (BMA) in Patients Treated for Over 2 Years for Bone Metastases From Either Breast or Castration-resistant Prostate Cancer

Study of Capmatinib in Indian Patients With MET Exon 14 Skipping Mutation Positive Advanced NSCLC.

The FLOTILLA Study: Providing Continued Access to The Study Medicines Encorafenib and Binimetinib for Participants in Prior Clinical Trials

A Randomized Trial Evaluating Personalized vs Guideline-based Well Follow-up Strategies for Patients With Early-stage Breast Cancer

ALPINIST

HU-F-AIM

REMERGE

TRANSPARENT

Nirogacestat in Premenopausal Females With Desmoid Tumor/Aggressive Fibromatosis (DT/AF)

Roll-over Study to Allow Access to Certinib (LDK378) for Patients Who Are on Ceritinib Treatment in a Novartis-sponsored Study

Pediatric Long-Term Follow-up and Rollover Study

Roll-over Study to Allow Continued Access to Ribociclib

A Phase IV Study of Safety and Efficacy of Everolimus in Taiwanese Patients With Tuberous Sclerosis Complex Who Have Renal Angiomyolipoma (TSC-AML)

REaCT-TEMPO

Study to Allow Access to Imatinib for Patients Who Are on Imatinib Treatment in a Novartis-sponsored Study and Are Benefiting From the Treatment as Judged by the Investigator

Dabrafenib and/or Trametinib Rollover Study

DOSABEMA

ctDNA-guided Addition of Ipilimumab to Patients Receiving Nivolumab and Relatlimab

SUP-R

Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer

Crizotinib Continuation Clinical Study

MINUTE

STOP-MED CTRCD

SMILE

A Clinical Study of Iparomlimab and Tuvonralimab Combined With SOX Following Heterogeneous Radiotherapy as First-line Treatment for Unresectable Locally Advanced or Metastatic HER2-negative Gastric or Gastroesophageal Junction Adenocarcinoma

Hyperbaric Oxygen Therapy for Soft Tissue Sarcoma Pilot Study

Phase 4 Study Evaluating Efficacy and Safety of Rozanolixizumab in Adult Chinese Participants With Generalized Myasthenia Gravis

Effect of Dexmedetomidine on Brain Homeostasis and Neurocognitive Outcome

ESPTTN